|
|
| (77 intermediate revisions by 5 users not shown) |
| Line 1: |
Line 1: |
| __NOTOC__ | | __NOTOC__ |
| {{SI}} | | {{Primary mediastinal large B-cell lymphoma}} |
| | '''For patient information, click [Primary mediastinal large B-cell lymphoma(patient information)|here]]''' |
|
| |
|
| '''For patient information, click [[Insert page name here (patient information)|Insert page name here]]'''
| | {{CMG}}; {{AE}} {{Badria}} {{AS}} |
|
| |
|
| {{CMG}}; {{AE}} {{AS}} | | {{SK}} |
|
| |
|
| {{SK}}:
| | ==[[Primary mediastinal large B-cell lymphoma overview|Overview]]== |
| == Overview == | |
|
| |
|
| | ==[[Primary mediastinal large B-cell lymphoma historical perspective|Historical Perspective]]== |
|
| |
|
| == Pathophysiology== | | ==[[Primary mediastinal large B-cell lymphoma classification|Classification]]== |
|
| |
|
| === Associated Conditions=== | | ==[[Primary mediastinal large B-cell lymphoma pathophysiology|Pathophysiology]]== |
|
| |
|
| ===Microscopic Pathology=== | | ==[[Primary mediastinal large B-cell lymphoma causes|Causes]]== |
| On microscopic histopathological analysis, centrocytes, centroblasts, plasma cells, and immunoblasts are characteristic findings of nodal marginal zone lymphoma.
| |
| ==Causes==
| |
| There are no established causes for primary mediastinal large B-cell lymphoma.
| |
| ==Differentiating type page name here from other Diseases==
| |
| Primary mediastinal large B-cell lymphoma must be differentiated from other diseases such as:
| |
|
| |
|
| == Epidemiology and Demographics == | | ==[[Primary mediastinal large B-cell lymphoma differential diagnosis|Differentiating Primary mediastinal large B-cell lymphoma from other Diseases]]== |
| ===Age===
| |
| The incidence of primary mediastinal large B-cell lymphoma increases with age; the median age at diagnosis is 35 years.
| |
| ===Gender===
| |
| Females are more commonly affected with primary mediastinal large B-cell lymphoma than males.
| |
| == Risk Factors ==
| |
| There are no established risk factors for primary mediastinal large B-cell lymphoma.
| |
| == Screening ==
| |
| According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for primary mediastinal large B-cell lymphoma.
| |
| == Natural History, Complications and Prognosis==
| |
|
| |
|
| == Diagnosis == | | ==[[Primary mediastinal large B-cell lymphoma epidemiology and demographics|Epidemiology and Demographics]]== |
| ===Staging===
| |
| Staging for primary mediastinal large B-cell lymphoma is provided in the following table:<ref>{{Cite journal| doi = 10.1200/JCO.2013.54.8800| issn = 1527-7755| volume = 32| issue = 27| pages = 3059–3068| last1 = Cheson| first1 = Bruce D.| last2 = Fisher| first2 = Richard I.| last3 = Barrington| first3 = Sally F.| last4 = Cavalli| first4 = Franco| last5 = Schwartz| first5 = Lawrence H.| last6 = Zucca| first6 = Emanuele| last7 = Lister| first7 = T. Andrew| last8 = Alliance, Australasian Leukaemia and Lymphoma Group| last9 = Eastern Cooperative Oncology Group| last10 = European Mantle Cell Lymphoma Consortium| last11 = Italian Lymphoma Foundation| last12 = European Organisation for Research| last13 = Treatment of Cancer/Dutch Hemato-Oncology Group| last14 = Grupo Español de Médula Ósea| last15 = German High-Grade Lymphoma Study Group| last16 = German Hodgkin's Study Group| last17 = Japanese Lymphorra Study Group| last18 = Lymphoma Study Association| last19 = NCIC Clinical Trials Group| last20 = Nordic Lymphoma Study Group| last21 = Southwest Oncology Group| last22 = United Kingdom National Cancer Research Institute| title = Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification| journal = Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology| date = 2014-09-20| pmid = 25113753}}</ref>
| |
|
| |
|
| {| style="border: 0px; font-size: 90%; margin: 3px;" align=center
| | ==[[Primary mediastinal large B-cell lymphoma risk factors|Risk Factors]]== |
| |+ '''Revised staging system for primary nodal lymphomas (Lugano classification)'''
| |
| ! style="background: #4479BA; color:#FFF;" | Stage
| |
| ! style="background: #4479BA; color:#FFF;" | Involvement
| |
| ! style="background: #4479BA; color:#FFF;" | Extranodal (E) status
| |
| |-
| |
| | style="padding: 5px 5px; background: #DCDCDC;" colspan=3 | '''Limited''' | |
| |-
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | Stage I
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | One node or a group of adjacent nodes
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | Single extranodal lesions without nodal involvement
| |
| |-
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | Stage II
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | Two or more nodal groups on the same side of the diaphragm
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | Stage I or II by nodal extent with limited contiguous extranodal involvement
| |
| |-
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | Stage II bulky
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | II as above with "bulky" disease
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | Not applicable
| |
| |-
| |
| | style="padding: 5px 5px; background: #DCDCDC;" colspan=3 | '''Advanced'''
| |
| |-
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | Stage III
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | Nodes on both sides of the diaphragm; nodes above the diaphragm with spleen involvement
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | Not applicable
| |
| |-
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | Stage IV
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | Additional noncontiguous extralymphatic involvement
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | Not applicable
| |
| |}
| |
|
| |
|
| === Symptoms === | | ==[[Primary mediastinal large B-cell lymphoma screening|Screening]]== |
| Symptoms of the primary mediastinal large B-cell lymphoma include:
| |
| * [[Fever]]
| |
| * [[Weight loss]]
| |
| * [[Night sweats]]
| |
| * Skin rash
| |
| * Painless swelling in the neck, axilla, groin, thorax, and abdomen
| |
| === Physical Examination ===
| |
| ====Vitals====
| |
| * [[Fever]] is often present
| |
| ====HEENT====
| |
| * [[Lymphadenopathy|Cervical lymphadenopathy]]
| |
| ====Thorax====
| |
| * Thoracic masses suggestive of [[Lymphadenopathy|central lymphadenopathy]]
| |
| * Localized anterosuperior mediastinal mass
| |
| ====Abdomen====
| |
| * [[Abdominal mass]]es suggestive of [[Lymphadenopathy|central lymphadenopathy]]
| |
| ====Extremities====
| |
| * [[Lymphadenopathy|Peripheral lymphadenopathy]]
| |
| ===Laboratory Findings ===
| |
| Laboratory tests for primary mediastinal large B-cell lymphoma include:
| |
| * [[Complete blood count]] (CBC)
| |
| * Blood chemistry studies
| |
| * Cytogenetic analysis
| |
| * [[Flow cytometry]]
| |
| * [[Immunohistochemistry]]
| |
| * [[Immunophenotyping]]:
| |
| :* Positive: [[CD19]], [[CD79a]], [[CD20]], [[CD30]], and [[CD22]]
| |
| ====Biopsy====
| |
| Lymph node or bone marrow biopsy is diagnostic of .
| |
| ====CT ====
| |
| [[CT]] scan may be helpful in the diagnosis of primary mediastinal large B-cell lymphoma.
| |
| ==== MRI ====
| |
| [[MRI]] scan may be helpful in the diagnosis of primary mediastinal large B-cell lymphoma.
| |
| ==== Other Imaging Findings ====
| |
| [[PET]] scan may be helpful in the diagnosis of primary mediastinal large B-cell lymphoma.
| |
| ==Treatment==
| |
| ===Medical Therapy===
| |
|
| |
|
| {| style="border: 0px; font-size: 90%; margin: 3px;" align=center
| | ==[[Primary mediastinal large B-cell lymphoma natural history, complications and prognosis|Natural History, Complications and Prognosis]]== |
| |+ '''Treatment of primary mediastinal large B-cell lymphoma<ref name= canadiancancer>Nodal marginal zone lymphoma . Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/nodal-marginal-zone-lymphoma/?region=nb Accessed on March 4, 2016 </ref>
| |
| ! style="background: #4479BA; color:#FFF;" | Therapy
| |
| ! style="background: #4479BA; color:#FFF;" | Description
| |
| |-
| |
| |-
| |
| | style="padding: 5px 5px; background: #DCDCDC;" | [[Chemotherapy]]
| |
| | style="padding: 5px 5px; background: #F5F5F5;" |
| |
|
| |
|
| |- | | ==Diagnosis== |
| | style="padding: 5px 5px; background: #DCDCDC;" | [[Biological therapy]] | | [[Primary mediastinal large B-cell lymphoma diagnostic study of choice|Diagnostic study of choice]] | [[Primary mediastinal large B-cell lymphoma history and symptoms|History and Symptoms]] | [[Primary mediastinal large B-cell lymphoma physical examination|Physical Examination]] | [[Primary mediastinal large B-cell lymphoma laboratory findings|Laboratory Findings]] | [[Primary mediastinal large B-cell lymphoma electrocardiogram|Electrocardiogram]] | [[Primary mediastinal large B-cell lymphoma x ray|X-Ray Findings]] | [[Primary mediastinal large B-cell lymphoma echocardiography and ultrasound|Echocardiography and Ultrasound]] | [[Primary mediastinal large B-cell lymphoma CT scan|CT-Scan Findings]] | [[Primary mediastinal large B-cell lymphoma MRI|MRI Findings]] | [[Primary mediastinal large B-cell lymphoma other imaging findings|Other Imaging Findings]] | [[Primary mediastinal large B-cell lymphoma other diagnostic studies|Other Diagnostic Studies]] |
| | style="padding: 5px 5px; background: #F5F5F5;" | | |
|
| |
|
| |-
| | ==Treatment== |
| | style="padding: 5px 5px; background: #DCDCDC;" | [[Radiation therapy]] | | [[Primary mediastinal large B-cell lymphoma medical therapy|Medical Therapy]] | [[Primary mediastinal large B-cell lymphoma surgery|Surgery]] | [[Primary mediastinal large B-cell lymphoma primary prevention|Primary Prevention]] | [[Primary mediastinal large B-cell lymphoma secondary prevention|Secondary Prevention]] | [[Primary mediastinal large B-cell lymphoma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Primary mediastinal large B-cell lymphoma future or investigational therapies|Future or Investigational Therapies]] |
| | style="padding: 5px 5px; background: #F5F5F5;" | | |
| | |
| |- | |
| | style="padding: 5px 5px; background: #DCDCDC;" | [[Stem cell transplant]] | |
| | style="padding: 5px 5px; background: #F5F5F5;" | | |
| | |
| |}
| |
|
| |
|
| ==References== | | ==Case Studies== |
| {{Reflist|2}}
| | [[rimary mediastinal large B-cell lymphoma case study one|Case #1]] |
|
| |
|
| [[Category:Disease]] | | [[Category: (oncology)]] |
| [[Category:Oncology]]
| |